INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

555 studies · page 17 of 24

2018 / Randomized controlled pilot trial

Intermittent and continuous energy restriction achieved similar weight loss in obese veterans.

Twenty-four obese male veterans were randomized to either a 5:2 intermittent energy-restricted diet or a standard daily energy-restricted diet for 6 months. Mean weight loss was 5.3 ± 3.0 kg (5.5 ± 3.2%) with the 5:2 diet and 5.5 ± 4.3 kg (5.4 ± 4.2%) with standard restriction, with no significant differences between groups for weight or waist reduction. Systolic blood pressure decreased in both groups, but neither regimen significantly shifted diastolic pressure, fasting glucose, or blood lipids.

Conley M, Le Fevre L, Haywood C, et al. Nutr Diet, 2018. PMID 28791787

2018 / Randomized controlled trial

Calorie restriction improved cardiometabolic risk markers in healthy nonobese adults over two years

In an ancillary randomized controlled trial of 53 healthy nonobese adults, 24 months of caloric restriction decreased body weight by 9 ± 0.5 kg, visceral adipose tissue by 0.5 ± 0.01 kg, and blood pressure (systolic -8 ± 3 mmHg; diastolic -6 ± 2 mmHg) compared to ad libitum eating. Total cholesterol fell by 13.6 ± 5.3 mg/dl, LDL-cholesterol decreased by 12.9 ± 4.4 mg/dl, and estimated 10-year cardiovascular risk dropped by 30%. Insulin resistance initially improved during weight loss, but this change was not maintained during weight maintenance.

Most J, Gilmore LA, Smith SR, et al. Am J Physiol Endocrinol Metab, 2018. PMID 29351490

2018 / Uncontrolled before-and-after intervention study

A 4-week defined plant-based diet reduced blood pressure, serum lipids, and medication usage in an outpatient clinic setting.

Participants in an outpatient cardiovascular clinic consumed a defined plant-based diet excluding all animal products and consisting of raw fruits, vegetables, seeds, and avocado for 4 weeks. Significant reductions were observed in systolic (-16.6 mmHg) and diastolic (-9.1 mmHg) blood pressure (P < 0.0005), serum lipids (P ≤ 0.008), and total medication usage (P < 0.0005). Reductions also occurred in weight (P < 0.0005), waist circumference (P < 0.0005), heart rate (P = 0.018), insulin (P < 0.0005), glycated hemoglobin (P = 0.002), and hs-CRP (P = 0.001).

Najjar RS, Moore CE, Montgomery BD Clin Cardiol, 2018. PMID 29575002

2018 / 2 x 6-week randomized, double-blind, placebo-controlled crossover trial

Chronic nicotinamide riboside supplementation is well-tolerated and stimulates NAD+ metabolism in healthy middle-aged and older adults.

In a 2 x 6-week randomized, double-blind, placebo-controlled crossover clinical trial, researchers assessed the effects of chronic supplementation with the NAD+ precursor nicotinamide riboside (NR) in healthy middle-aged and older adults. Chronic NR supplementation was well tolerated and effectively stimulated NAD+ metabolism. The results suggest that future clinical trials should further evaluate the potential benefits of NR for reducing blood pressure and arterial stiffness in this population.

Martens CR, Denman BA, Mazzo MR, et al. Nat Commun, 2018. PMID 29599478

2018 / Supervised controlled feeding randomized crossover trial

Early time-restricted feeding improved insulin sensitivity, blood pressure, and oxidative stress without weight loss in men with prediabetes.

Researchers conducted a supervised controlled feeding trial to determine if intermittent fasting provides benefits independent of weight loss by feeding participants enough food to maintain weight. Men with prediabetes were randomized to early time-restricted feeding (a 6-hour feeding window with dinner before 3 p.m.) or a control schedule (12-hour feeding period) for 5 weeks, followed by crossover to the alternate schedule. Early time-restricted feeding improved insulin sensitivity, β cell responsiveness, blood pressure, oxidative stress, and appetite without weight loss.

Sutton EF, Beyl R, Early KS, et al. Cell Metab, 2018. PMID 29754952

2018 / Randomized controlled trial

Intermittent and continuous calorie restriction produced comparable 1-year weight loss.

In a 1-year randomized trial, 112 adults with abdominal obesity underwent 6 months of active weight loss followed by 6 months of maintenance. Average weight loss was 8.0 kg (SD 6.5) with intermittent restriction and 9.0 kg (SD 7.1) with continuous restriction (p = 0.6), and weight regain was similar (1.1 kg vs 0.4 kg). Both diets improved blood pressure, waist circumference, triglycerides, and HDL cholesterol equally, though the intermittent group reported higher hunger scores (4.7 vs 3.6, p = 0.002).

Sundfør TM, Svendsen M, Tonstad S Nutr Metab Cardiovasc Dis, 2018. PMID 29778565

2018 / Double-blind, placebo-controlled randomized trial

A combination of hibiscus and lemon verbena polyphenols improved anthropometric measurements, lowered blood pressure, and modulated appetite hormones.

A double-blind, placebo-controlled trial evaluated a dietary supplement combining Lippia citriodora and Hibiscus sabdariffa polyphenolic extracts over 60 days in 54 overweight participants. Results showed improvements in anthropometric measurements, reductions in blood pressure and heart rate, and improved subjective health status. Furthermore, the extract combination increased the anorexigenic hormone glucagon-like peptide-1 and decreased the orexigenic hormone ghrelin.

Boix-Castejón M, Herranz-López M, Pérez Gago A, et al. Food Funct, 2018. PMID 29862395

2018 / Intervention trial with matched historical controls

An 8-hour time-restricted feeding regimen reduced body weight, energy intake, and systolic blood pressure in obese adults compared to historical controls.

Obese participants (n = 23) adhered to an 8-h time-restricted feeding regimen (ad libitum feeding 10:00 to 18:00 h, water fasting 18:00 to 10:00 h) for 12 weeks, compared against 23 matched historical controls. Over 12 weeks, body weight decreased by -2.6% ± 0.5 and energy intake by -341 ± 53 kcal/d relative to controls (P < 0.05). Systolic blood pressure also fell (-7 ± 2 mm Hg vs controls, P < 0.05). Fat mass, lean mass, visceral fat mass, diastolic blood pressure, LDL cholesterol, HDL cholesterol, triglycerides, fasting glucose, fasting insulin, HOMA-IR, and homocysteine did not differ significantly between groups.

Gabel K, Hoddy KK, Haggerty N, et al. Nutr Healthy Aging, 2018. PMID 29951594

2018 / Randomized crossover trial

Substituting modern wheat with ancient KAMUT khorasan wheat mildly improved blood pressure, glucose, and endothelial reactivity in pre-hypertensive adults.

A randomized, crossover trial in 63 non-diabetic pre-hypertensive volunteers evaluated the effects of 4-week diets with ancient wheat products (organic KAMUT khorasan) versus modern wheat products. Ancient wheat intake resulted in significant improvements in triglycerides (-9.8% vs. baseline, -14.5% vs. modern wheat), fasting plasma glucose (-4.3% vs. baseline, -31.6% vs. modern wheat), diurnal SBP (-3.1% vs. baseline, -30.2% vs. modern wheat), nocturnal SBP (-3.2% vs. baseline, -36.8% vs. modern wheat), and pulse volume change (+4.2% vs. baseline, +2.3% vs. modern wheat) (all p < 0.05). The authors concluded that replacing modern wheat with ancient wheat might exert a mild improvement in 24-hour SBP and endothelial reactivity.

Cicero AFG, Fogacci F, Veronesi M, et al. Nutrients, 2018. PMID 30400372

2017 / Randomized controlled trial

Hibiscus sabdariffa extract increased urine volume and creatinine clearance compared to placebo in Nigerians with mild to moderate hypertension.

A total of 78 newly diagnosed but untreated hypertensive subjects were randomized into three equal groups receiving Hibiscus sabdariffa (HS), lisinopril, or placebo once daily for 4 weeks. HS and lisinopril both significantly increased urine volume compared to placebo (P < 0.001), with HS increasing it significantly more than lisinopril (P < 0.001). Additionally, HS significantly increased creatinine clearance compared to placebo (P < 0.001), whereas lisinopril did not.

Nwachukwu DC, Aneke EI, Nwachukwu NZ, et al. J Physiol Sci, 2017. PMID 27221151

2017 / Repeated-measures crossover trial

Energy drink consumption increased exercise systolic blood pressure without improving running economy or perceived exertion in recreational runners.

Fifteen recreational runners completed a graded exercise protocol followed by four 15-minute treadmill economy trials at 70% of VO2max, conducted 1 hour after consuming one of three energy drinks or a placebo. Fifteen-minute systolic blood pressure was significantly lower in the placebo trials (156.93 ± 15.50) compared to the three energy drink trials (163.87 ± 13.30, 166.47 ± 13.71, and 165.00 ± 15.23). No significant differences were observed for diastolic blood pressure, heart rate, VO2, or rating of perceived exertion.

Peveler WW, Sanders GJ, Marczinski CA, et al. J Strength Cond Res, 2017. PMID 27386963

2017 / Randomized controlled trial

Yeast beta-glucan reduced waist circumference, blood pressure, and inflammation in overweight adults

A randomized, double-blind trial gave 44 overweight or obese adults either yeast beta-glucan (up to 954 mg daily) or placebo for six weeks. Compared to placebo, beta-glucan significantly reduced waist circumference (p = 0.037), blood pressure (p = 0.006), and IL-6 at week six (p = 0.005), while increasing IL-10 (p < 0.001). No significant differences appeared in lipid profiles, liver and kidney markers, or nutrient intake.

Mosikanon K, Arthan D, Kettawan A, et al. J Diet Suppl, 2017. PMID 27715351

2017 / Randomized controlled crossover trial

A fasting-mimicking diet reduced body fat, blood pressure, and disease risk factors.

In a randomized trial involving 100 healthy participants, three monthly 5-day cycles of a fasting-mimicking diet reduced body weight, trunk fat, total body fat, blood pressure, and insulin-like growth factor 1. Crossover of the control group resulted in 71 participants finishing three cycles without serious adverse effects. A post hoc analysis revealed that improvements in blood pressure, fasting glucose, cholesterol, triglycerides, and C-reactive protein were greater in individuals initially at risk for disease.

Wei M, Brandhorst S, Shelehchi M, et al. Sci Transl Med, 2017. PMID 28202779

2017 / Randomized crossover trial

Circadian misalignment in chronic shift workers significantly increased 24-hour hs-CRP and blood pressure levels.

Chronic shift workers completed two 3-day laboratory protocols simulating night work (12-hour inverted cycles; circadian misalignment) or day work (circadian alignment) in a randomized crossover design. Circadian misalignment increased 24-h hs-CRP by 11% (p < 0.0001) and increased 24-h systolic blood pressure (SBP) by 1.4 mmHg and diastolic blood pressure (DBP) by 0.8 mmHg (both p ≤ 0.038). The increase in 24-h SBP was primarily driven by an increase during wakefulness (+1.7 mmHg; p = 0.017), while the increase in 24-h DBP was mainly during sleep opportunity (+1.8 mmHg; p = 0.005).

Morris CJ, Purvis TE, Mistretta J, et al. J Biol Rhythms, 2017. PMID 28347188

2017 / Randomized controlled explorative pilot trial

A 7-day fasting program reduced weight, abdominal circumference, and blood pressure in patients with type 2 diabetes at 4 months.

In an explorative trial, patients with type 2 diabetes were randomized to a 7-day fasting program (Buchinger method, ~300 kcal/day liquids) followed by dietary advice, or to usual care with dietary advice only. Of 46 enrolled participants, 32 completed the 4-month trial. After 4 months, mean weight decreased by 3.5 kg in the fasting group compared to 2.0 kg in controls (p=0.03), accompanied by a greater reduction in abdominal circumference (p=0.001). Fasting also resulted in a significant decrease in systolic (p=0.01) and diastolic (p=0.003) blood pressure, as well as increased quality of life (p=0.04), while improvements in HbA1c, insulin, and HOMA-index were non-significant.

Li C, Sadraie B, Steckhan N, et al. Exp Clin Endocrinol Diabetes, 2017. PMID 28407662

2017 / Randomized crossover trial

Energy drinks prolonged QTc and increased systolic blood pressure more than caffeine alone.

In a randomized crossover trial of 18 healthy adults, participants drank 946 mL of an energy drink or a caffeine-matched control beverage. At 2 hours, the corrected QT interval change was significantly greater following the energy drink compared to caffeine alone (0.44±18.4 ms versus -10.4±14.8 ms; P=0.02). Systolic blood pressure was also higher at 6 hours post-consumption (4.72±4.67 mm Hg versus 0.83±6.09 mm Hg; P=0.01), with no differences observed in diastolic blood pressure or heart rate.

Fletcher EA, Lacey CS, Aaron M, et al. J Am Heart Assoc, 2017. PMID 28446495

2017 / Multicenter, random-order, double-blind observational and interventional study

Enjoyment of spicy foods may significantly reduce individual salt preference, daily salt intake, and blood pressure by modifying central salty-taste processing.

In a multicenter, random-order, double-blind observational and interventional study, subjects with a high spice preference had a lower salt intake and blood pressure than subjects who disliked spicy food. Enjoyment of spicy flavor enhanced salt sensitivity and reduced salt preference, with salt intake and preference related to metabolic activity in the insula and orbitofrontal cortex (OFC). Capsaicin administration enhanced insula and OFC metabolic activity in response to high-salt stimuli, reversing salt intensity-dependent differences in metabolism.

Li Q, Cui Y, Jin R, et al. Hypertension, 2017. PMID 29089370

2017 / Prospective randomized placebo-controlled study

Moringa oleifera leaf capsules (8 g/day) had no significant effect on glycemic control in therapy-naïve type 2 diabetes patients.

Thirty-two therapy-naïve type 2 diabetes patients were randomized to receive either 8 grams per day of Moringa oleifera (MO) leaf capsules or placebo for 4 weeks. There was no significant difference in FPG and HbA1C between groups, and no adverse effects were observed. The MO leaf group experienced a 5 mmHg reduction in systolic blood pressure compared to baseline, but this change was not statistically significant.

Taweerutchana R, Lumlerdkij N, Vannasaeng S, et al. Evid Based Complement Alternat Med, 2017. PMID 29317895

2016 / Randomized, double-blind, placebo-controlled trial

Taurine supplementation for 12 weeks significantly reduced blood pressure and improved vascular function in prehypertensive individuals.

A randomized, double-blind, placebo-controlled study assigned 120 prehypertensive individuals to receive 1.6 g per day of taurine or a placebo for 12 weeks. Taurine supplementation significantly decreased clinic systolic BP (mean reduction: 7.2 vs. 2.6 mm Hg for placebo) and diastolic BP (4.7 vs. 1.3 mm Hg), as well as ambulatory systolic BP (3.8 vs. 0.3 mm Hg) and diastolic BP (3.5 vs. 0.6 mm Hg). Supplementation also improved endothelium-dependent and endothelium-independent vasodilation and increased plasma H2S and taurine concentrations, which negatively correlated with BP changes.

Sun Q, Wang B, Li Y, et al. Hypertension, 2016. PMID 26781281

2016 / Randomized controlled laboratory trial (two 8-d protocols)

Short-term circadian misalignment increased 24-hour blood pressure and inflammatory markers in healthy adults.

Researchers evaluated the impact of short-term circadian misalignment (12-h inverted behavioral and environmental cycles for 3 days) using two 8-day laboratory protocols in healthy adults. Circadian misalignment increased 24-h systolic blood pressure (SBP) by 3.0 mmHg and diastolic blood pressure (DBP) by 1.5 mmHg, driven mostly by increases during sleep opportunities (SBP, +5.6 mmHg; DBP, +1.9 mmHg). It also decreased wake cardiac vagal modulation by 8-15%, decreased 24-h urinary epinephrine excretion by 7% without affecting norepinephrine, and increased 24-h serum interleukin-6, C-reactive protein, resistin, and tumor necrosis factor-α levels by 3-29%.

Morris CJ, Purvis TE, Hu K, et al. Proc Natl Acad Sci U S A, 2016. PMID 26858430

2016 / Randomized crossover trial

Concord grape juice improved spatial memory and driving performance in working mothers

In a randomized crossover trial, 25 working mothers aged 40 to 50 years drank 355 mL of Concord grape juice or placebo daily for 12 weeks with a four-week washout. Consumption of the grape juice led to significant improvements in immediate spatial memory compared to placebo. In a subset of 17 participants, grape juice also improved performance during a simulated driving task, with benefits persisting into the subsequent placebo phase.

Lamport DJ, Lawton CL, Merat N, et al. Am J Clin Nutr, 2016. PMID 26864371

2016 / Double-blind placebo-controlled randomized trial

Roselle calyx powder significantly decreased systolic blood pressure and serum triglycerides in adults with metabolic syndrome.

Forty adults with metabolic syndrome were randomly assigned to receive either 500 mg of Hibiscus sabdariffa calyx powder or placebo once daily for 4 weeks. Compared to placebo, H. sabdariffa significantly reduced serum triglycerides (p=0.044) and systolic blood pressure (p=0.049). All other measured variables—including diastolic blood pressure, BMI, fasting plasma glucose, insulin, lipoproteins, hs-CRP, and malondialdehyde—were not significantly affected.

Asgary S, Soltani R, Zolghadr M, et al. J Complement Integr Med, 2016. PMID 26982618

2016 / Randomized controlled trial

Adding flaxseed to lifestyle advice reduced metabolic syndrome prevalence and insulin resistance

A randomized trial assigned 44 patients with metabolic syndrome to lifestyle advice alone or with 30 grams of milled flaxseed daily. Metabolic syndrome rates dropped by 82% in the flaxseed group compared to 50% in controls. The flaxseed group experienced greater reductions in insulin resistance (p < 0.001), body weight, waist circumference, and body mass index, although blood pressure showed no significant alterations.

Yari Z, Rahimlou M, Poustchi H, et al. Phytother Res, 2016. PMID 27151322

2016 / Randomized controlled trial

Flaxseed reduced central blood pressure in participants with high baseline blood pressure.

Among 62 patients with peripheral artery disease who had high blood pressure at baseline, dietary flaxseed lowered central systolic and diastolic blood pressures by an average of 10 and 6 mm Hg compared to placebo. Flaxseed did not significantly alter the augmentation index or other cardiac function indices. The reduction in central blood pressure was linked to decreases in specific plasma oxylipins, including 16-hydroxyeicosatetraenoic acid and thromboxane B2.

Caligiuri SP, Rodriguez-Leyva D, Aukema HM, et al. Hypertension, 2016. PMID 27528063